Upregulation of Oxytocin Receptor in the Hyperplastic Prostate

Background: The etiology of benign prostatic hyperplasia (BPH) is complex, both age and androgen are thought to be important. However, the failure of androgen blockade treatments suggests other paracrine/autocrine factors involved in BPH. Oxytocin was found to have a paracrine/autocrine role in pros...

Full description

Bibliographic Details
Main Authors: Zhuo Li, He Xiao, Kebing Wang, Yuelan Zheng, Ping Chen, Xinghuan Wang, Michael E. DiSanto, Xinhua Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2018.00403/full
_version_ 1819071509016084480
author Zhuo Li
Zhuo Li
He Xiao
Kebing Wang
Yuelan Zheng
Ping Chen
Xinghuan Wang
Michael E. DiSanto
Xinhua Zhang
author_facet Zhuo Li
Zhuo Li
He Xiao
Kebing Wang
Yuelan Zheng
Ping Chen
Xinghuan Wang
Michael E. DiSanto
Xinhua Zhang
author_sort Zhuo Li
collection DOAJ
description Background: The etiology of benign prostatic hyperplasia (BPH) is complex, both age and androgen are thought to be important. However, the failure of androgen blockade treatments suggests other paracrine/autocrine factors involved in BPH. Oxytocin was found to have a paracrine/autocrine role in prostate in recent years. The influence of BPH on prostatic oxytocin receptor (OTR) expression has never been studied.Material and methods: A testosterone-estradiol induced rat model of BPH was employed and human hyperplastic prostate specimens were harvested. Expressions of OTR, α1-adrenoreceptor subtypes and nitric oxide synthase isoforms were determined via real-time RT-PCR. OTR was further analyzed with Western-Blotting and histological examination. Subsequently, rat epithelial cells, human stromal cells and epithelial cells were cultured in vitro and treated with gradient concentrations of OT from 1 to 5 days. Cell proliferation was tested by Cell Counting Kit-8 and Flow Cytometry.Results: The rat BPH model was validated with significant increased prostate weight. H-E stain revealed a different histopathology between human and rat BPH. Masson's trichrome staining demonstrated that smooth muscle (SM) cells, epithelium cells and collagen fibers were simultaneously augmented in this rat BPH model and human BPH samples. OTR mainly localized in epithelium in rat prostate whereas it mainly localized in stroma in human prostate. OTR gene was upregulated 3.3-fold in rat BPH and 3.0-fold in human BPH, along with increased expression of 2.0-fold α1aARs and 3.0-fold eNOS for rat BPH and 5.0-fold α1aARs for human BPH. The expression of OTR protein was upregulated 1.4-fold in rat BPH and 3.9-fold in human BPH, respectively. Increased concentrations of exogenous OT can accelerate proliferation of rat epithelial cells and human stromal cells but has no impact on human epithelial cells in vitro. Flow Cytometry showed oxytocin could significantly increase G2/M period cell number.Conclusions: Our novel data demonstrates a significant and previously undocumented upregulation of OTR in both rat and human BPH. Moreover, exogenous OT accelerates proliferation of rat prostate epithelial cells and human prostate stromal cells. It is suggested OTR is involved in the development of BPH and OT regulatory system could be a potential new target for the BPH treatment.
first_indexed 2024-12-21T17:22:57Z
format Article
id doaj.art-c0a1d06322b943e5bb5fed9880d0b34c
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-21T17:22:57Z
publishDate 2018-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-c0a1d06322b943e5bb5fed9880d0b34c2022-12-21T18:56:07ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922018-08-01910.3389/fendo.2018.00403378182Upregulation of Oxytocin Receptor in the Hyperplastic ProstateZhuo Li0Zhuo Li1He Xiao2Kebing Wang3Yuelan Zheng4Ping Chen5Xinghuan Wang6Michael E. DiSanto7Xinhua Zhang8Zhongnan Hospital of Wuhan University, Wuhan, ChinaShenzhen Key Laboratory for Endogenous Infection, Department of Urology, Shenzhen Sixth People's Hospital, The Sixth Affiliated Hospital of Shenzhen University Health Science Center, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, ChinaZhongnan Hospital of Wuhan University, Wuhan, ChinaShenzhen Key Laboratory for Endogenous Infection, Department of Urology, Shenzhen Sixth People's Hospital, The Sixth Affiliated Hospital of Shenzhen University Health Science Center, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, ChinaDepartment of General Surgery, Children's Hospital of Shenzhen, Shenzhen, ChinaZhongnan Hospital of Wuhan University, Wuhan, ChinaZhongnan Hospital of Wuhan University, Wuhan, ChinaDepartments of Biomedical Sciences, Surgery of Cooper Medical School of Rowan University, Camden, NJ, United StatesZhongnan Hospital of Wuhan University, Wuhan, ChinaBackground: The etiology of benign prostatic hyperplasia (BPH) is complex, both age and androgen are thought to be important. However, the failure of androgen blockade treatments suggests other paracrine/autocrine factors involved in BPH. Oxytocin was found to have a paracrine/autocrine role in prostate in recent years. The influence of BPH on prostatic oxytocin receptor (OTR) expression has never been studied.Material and methods: A testosterone-estradiol induced rat model of BPH was employed and human hyperplastic prostate specimens were harvested. Expressions of OTR, α1-adrenoreceptor subtypes and nitric oxide synthase isoforms were determined via real-time RT-PCR. OTR was further analyzed with Western-Blotting and histological examination. Subsequently, rat epithelial cells, human stromal cells and epithelial cells were cultured in vitro and treated with gradient concentrations of OT from 1 to 5 days. Cell proliferation was tested by Cell Counting Kit-8 and Flow Cytometry.Results: The rat BPH model was validated with significant increased prostate weight. H-E stain revealed a different histopathology between human and rat BPH. Masson's trichrome staining demonstrated that smooth muscle (SM) cells, epithelium cells and collagen fibers were simultaneously augmented in this rat BPH model and human BPH samples. OTR mainly localized in epithelium in rat prostate whereas it mainly localized in stroma in human prostate. OTR gene was upregulated 3.3-fold in rat BPH and 3.0-fold in human BPH, along with increased expression of 2.0-fold α1aARs and 3.0-fold eNOS for rat BPH and 5.0-fold α1aARs for human BPH. The expression of OTR protein was upregulated 1.4-fold in rat BPH and 3.9-fold in human BPH, respectively. Increased concentrations of exogenous OT can accelerate proliferation of rat epithelial cells and human stromal cells but has no impact on human epithelial cells in vitro. Flow Cytometry showed oxytocin could significantly increase G2/M period cell number.Conclusions: Our novel data demonstrates a significant and previously undocumented upregulation of OTR in both rat and human BPH. Moreover, exogenous OT accelerates proliferation of rat prostate epithelial cells and human prostate stromal cells. It is suggested OTR is involved in the development of BPH and OT regulatory system could be a potential new target for the BPH treatment.https://www.frontiersin.org/article/10.3389/fendo.2018.00403/fulloxytocinreceptorprostatebenign prostatic hyperplasiaandrogenestrogen
spellingShingle Zhuo Li
Zhuo Li
He Xiao
Kebing Wang
Yuelan Zheng
Ping Chen
Xinghuan Wang
Michael E. DiSanto
Xinhua Zhang
Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
Frontiers in Endocrinology
oxytocin
receptor
prostate
benign prostatic hyperplasia
androgen
estrogen
title Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_full Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_fullStr Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_full_unstemmed Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_short Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_sort upregulation of oxytocin receptor in the hyperplastic prostate
topic oxytocin
receptor
prostate
benign prostatic hyperplasia
androgen
estrogen
url https://www.frontiersin.org/article/10.3389/fendo.2018.00403/full
work_keys_str_mv AT zhuoli upregulationofoxytocinreceptorinthehyperplasticprostate
AT zhuoli upregulationofoxytocinreceptorinthehyperplasticprostate
AT hexiao upregulationofoxytocinreceptorinthehyperplasticprostate
AT kebingwang upregulationofoxytocinreceptorinthehyperplasticprostate
AT yuelanzheng upregulationofoxytocinreceptorinthehyperplasticprostate
AT pingchen upregulationofoxytocinreceptorinthehyperplasticprostate
AT xinghuanwang upregulationofoxytocinreceptorinthehyperplasticprostate
AT michaeledisanto upregulationofoxytocinreceptorinthehyperplasticprostate
AT xinhuazhang upregulationofoxytocinreceptorinthehyperplasticprostate